Ufomadu Promise, Gill Bartley Joseph, Rosen Theodore, Shmizu Ikue, Orengo Ida
Mr. Ufomadu, Drs. Gill, Orengo, Rosen, and Shmizu are with the School of Medicine at Baylor College of Medicine in Houston, Texas.
Dr. Gill is also with Memorial Hermann Health Systems in Houston, Texas.
J Clin Aesthet Dermatol. 2025 Jun;18(6):29-40.
Lately, there has been a growing demand for the utilization of complementary and alternative medicines (CAMs) with dermatological applications. This is true despite limited RCT-level studies on such agents. This presents a barrier for dermatologists and fellow clinicians in counseling patients who may be using or are tempted to use these CAM modalities. This review highlights CAM agents used by patients for applications in cosmetic and surgical dermatology, exploring their efficacy and toxicity profiles.
A comprehensive review was conducted on the effectiveness of several CAMs utilized in cosmetic and surgical dermatology by patients. A literature search was performed using PubMed, Embase, Google Scholar, Web of Science, and Cochrane.
Most CAM agents studied had statistically insignificant results, and for CAM agents that had significant results in efficacy, the studies were questionable due to flawed randomization, lack of proper blinding, faulty data analysis, poor study design, suggestion of bias, small sample size, and limited clinical application.
CAM agents have promising potential in dermatologic use; however, more RCT-level studies are needed. A study design that either emphasizes a comparison between the CAM agent and conventional therapy, or the CAM agent with or without conventional therapy should be incorporated in future studies. As of now, dermatologists should be cognizant of bias in published studies demonstrating the effectiveness of certain CAM agents, as well as the possible adverse effects.
最近,对具有皮肤科应用的补充和替代药物(CAMs)的需求不断增长。尽管关于此类药物的随机对照试验(RCT)水平的研究有限,但情况确实如此。这给皮肤科医生和其他临床医生在为可能正在使用或倾向于使用这些CAM方式的患者提供咨询时带来了障碍。本综述重点介绍了患者在美容和外科皮肤科应用中使用的CAM药物,探讨了它们的疗效和毒性特征。
对患者在美容和外科皮肤科使用的几种CAM的有效性进行了全面综述。使用PubMed、Embase、谷歌学术、科学网和考克兰进行文献检索。
大多数研究的CAM药物结果在统计学上无显著意义,对于在疗效上有显著结果的CAM药物,由于随机化存在缺陷、缺乏适当的盲法、数据分析错误、研究设计不佳、存在偏倚迹象、样本量小以及临床应用有限,这些研究存在问题。
CAM药物在皮肤科应用中有广阔的潜力;然而,需要更多的RCT水平研究。未来的研究应纳入强调CAM药物与传统疗法之间比较,或CAM药物与传统疗法联合或不联合使用的研究设计。目前,皮肤科医生应认识到已发表的证明某些CAM药物有效性的研究中的偏倚以及可能的不良反应。